miR-101 plays a role in the formation of preeclampsia by reducing its expression, resulting in the inhibition of the NF-κB/CXCL11 signaling pathway and ultimately enhancing the proliferation and movement capabilities of placental trophoblast cells. Here, NFKB1 is linked to preeclampsia.